S&P 500   4,374.37 (-1.55%)
DOW   34,481.97 (-1.11%)
QQQ   363.04 (-1.97%)
AAPL   143.26 (-1.45%)
MSFT   286.61 (-2.57%)
FB   342.33 (-3.18%)
GOOGL   2,721.35 (-3.55%)
TSLA   783.92 (-0.94%)
AMZN   3,325.86 (-2.35%)
NVDA   208.32 (-3.82%)
BABA   150.10 (-0.05%)
NIO   35.86 (-2.47%)
CGC   14.49 (-1.50%)
GE   104.98 (-0.35%)
MU   73.40 (-2.37%)
AMD   104.46 (-3.42%)
T   27.44 (+0.15%)
F   14.33 (+1.20%)
ACB   6.78 (+6.10%)
DIS   175.13 (-1.76%)
PFE   42.49 (-2.48%)
BA   220.61 (-1.58%)
AMC   37.87 (-3.64%)
S&P 500   4,374.37 (-1.55%)
DOW   34,481.97 (-1.11%)
QQQ   363.04 (-1.97%)
AAPL   143.26 (-1.45%)
MSFT   286.61 (-2.57%)
FB   342.33 (-3.18%)
GOOGL   2,721.35 (-3.55%)
TSLA   783.92 (-0.94%)
AMZN   3,325.86 (-2.35%)
NVDA   208.32 (-3.82%)
BABA   150.10 (-0.05%)
NIO   35.86 (-2.47%)
CGC   14.49 (-1.50%)
GE   104.98 (-0.35%)
MU   73.40 (-2.37%)
AMD   104.46 (-3.42%)
T   27.44 (+0.15%)
F   14.33 (+1.20%)
ACB   6.78 (+6.10%)
DIS   175.13 (-1.76%)
PFE   42.49 (-2.48%)
BA   220.61 (-1.58%)
AMC   37.87 (-3.64%)
S&P 500   4,374.37 (-1.55%)
DOW   34,481.97 (-1.11%)
QQQ   363.04 (-1.97%)
AAPL   143.26 (-1.45%)
MSFT   286.61 (-2.57%)
FB   342.33 (-3.18%)
GOOGL   2,721.35 (-3.55%)
TSLA   783.92 (-0.94%)
AMZN   3,325.86 (-2.35%)
NVDA   208.32 (-3.82%)
BABA   150.10 (-0.05%)
NIO   35.86 (-2.47%)
CGC   14.49 (-1.50%)
GE   104.98 (-0.35%)
MU   73.40 (-2.37%)
AMD   104.46 (-3.42%)
T   27.44 (+0.15%)
F   14.33 (+1.20%)
ACB   6.78 (+6.10%)
DIS   175.13 (-1.76%)
PFE   42.49 (-2.48%)
BA   220.61 (-1.58%)
AMC   37.87 (-3.64%)
S&P 500   4,374.37 (-1.55%)
DOW   34,481.97 (-1.11%)
QQQ   363.04 (-1.97%)
AAPL   143.26 (-1.45%)
MSFT   286.61 (-2.57%)
FB   342.33 (-3.18%)
GOOGL   2,721.35 (-3.55%)
TSLA   783.92 (-0.94%)
AMZN   3,325.86 (-2.35%)
NVDA   208.32 (-3.82%)
BABA   150.10 (-0.05%)
NIO   35.86 (-2.47%)
CGC   14.49 (-1.50%)
GE   104.98 (-0.35%)
MU   73.40 (-2.37%)
AMD   104.46 (-3.42%)
T   27.44 (+0.15%)
F   14.33 (+1.20%)
ACB   6.78 (+6.10%)
DIS   175.13 (-1.76%)
PFE   42.49 (-2.48%)
BA   220.61 (-1.58%)
AMC   37.87 (-3.64%)
NYSE:BIO.B

Bio-Rad Laboratories Stock Forecast, Price & News

$759.90
-28.85 (-3.66 %)
(As of 09/27/2021 12:00 AM ET)
Add
Compare
Today's Range
$759.91
$759.91
50-Day Range
$675.25
$818.60
52-Week Range
$321.42
$538.00
Volume122 shs
Average Volume114 shs
Market Capitalization$22.62 billion
P/E Ratio5.66
Dividend YieldN/A
Beta0.77
30 days | 90 days | 365 days | Advanced Chart
Receive BIO.B News and Ratings via Email

Sign-up to receive the latest news and ratings for Bio-Rad Laboratories and its competitors with MarketBeat's FREE daily newsletter.


Bio-Rad Laboratories logo

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. develops, manufactures, and markets life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Headlines

Bio-Rad Laboratories (NYSE:BIO.B) Sets New 52-Week High at $818.60
September 10, 2021 |  americanbankingnews.com
Bio-Rad Laboratories (BIO)
August 25, 2021 |  forbes.com
Quidel Corp.
December 5, 2020 |  barrons.com
Bio-Rad Laboratories Inc. Buy
August 18, 2020 |  markets.businessinsider.com
Bio Rad Laboratories Inc
November 21, 2019 |  markets.ft.com
See More Headlines

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSE:BIO.B
Employees
8,000
Year Founded
1952

Sales & Book Value

Annual Sales
$2.55 billion
Cash Flow
$9.87 per share
Book Value
$331.05 per share

Profitability

Net Income
$3.81 billion

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$22.62 billion
Next Earnings Date
11/4/2021 (Estimated)
Optionable
Not Optionable

Social Links


MarketRank

Overall MarketRank

1.36 out of 5 stars

Medical Sector

1099th out of 1,353 stocks

Analytical Instruments Industry

28th out of 30 stocks

Analyst Opinion: 0.0Community Rank: 3.9Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -












Bio-Rad Laboratories (NYSE:BIO.B) Frequently Asked Questions

What stocks does MarketBeat like better than Bio-Rad Laboratories?

Wall Street analysts have given Bio-Rad Laboratories a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Bio-Rad Laboratories wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Bio-Rad Laboratories' next earnings date?

Bio-Rad Laboratories is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Bio-Rad Laboratories
.

How were Bio-Rad Laboratories' earnings last quarter?

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) issued its quarterly earnings data on Thursday, July, 29th. The company reported $3.54 earnings per share (EPS) for the quarter. The business earned $715.93 million during the quarter. Bio-Rad Laboratories had a net margin of 140.48% and a trailing twelve-month return on equity of 4.65%.
View Bio-Rad Laboratories' earnings history
.

How has Bio-Rad Laboratories' stock been impacted by COVID-19 (Coronavirus)?

Bio-Rad Laboratories' stock was trading at $350.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BIO.B stock has increased by 125.4% and is now trading at $788.75.
View which stocks have been most impacted by COVID-19
.

Who are Bio-Rad Laboratories' key executives?

Bio-Rad Laboratories' management team includes the following people:
  • Mr. Norman D. Schwartz, Chairman, CEO & Pres (Age 71, Pay $3.01M)
  • Mr. Ilan Daskal, Exec. VP & CFO (Age 55, Pay $1.16M)
  • Dr. Andrew J. Last, Exec. VP & COO (Age 61, Pay $1.5M)
  • Ms. Annette Tumolo, Exec. VP & Pres of Life Science Group (Age 66, Pay $1.05M)
  • Ms. Dara Grantham Wright, Exec. VP & Pres of Clinical Diagnostics Group (Age 45, Pay $1.39M)
  • Mr. Ajit Ramalingam, Sr. VP & Chief Accounting Officer (Age 48)
  • Diane Dahowski, Sr. VP of Global Technology & Systems
  • Mr. Timothy S. Ernst, Exec. VP, Gen. Counsel & Sec. (Age 61)
  • Colleen Corey, Sr. VP of Global HR
  • Mr. Michael Crowley, Exec. VP of Global Commercial Operations (Age 59)

What is Bio-Rad Laboratories' stock symbol?

Bio-Rad Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "BIO.B."

How do I buy shares of Bio-Rad Laboratories?

Shares of BIO.B can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bio-Rad Laboratories' stock price today?

One share of BIO.B stock can currently be purchased for approximately $788.75.

How much money does Bio-Rad Laboratories make?

Bio-Rad Laboratories has a market capitalization of $23.48 billion and generates $2.55 billion in revenue each year.

How many employees does Bio-Rad Laboratories have?

Bio-Rad Laboratories employs 8,000 workers across the globe.

Does Bio-Rad Laboratories have any subsidiaries?

The following companies are subsidiares of Bio-Rad Laboratories: BIO-RAD spol. s r.o., Bio-Metrics (U.K.) Limited, Bio-Metrics Limited, Bio-Metrics Properties Limited, Bio-Rad (France), Bio-Rad (Shanghai) Life Science Research & Development Co. Ltd., Bio-Rad 1, Bio-Rad AbD Serotec GmbH, Bio-Rad AbD Serotec Ltd, Bio-Rad China Ltd., Bio-Rad Denmark ApS, Bio-Rad Europe GmbH, Bio-Rad Export LLC, Bio-Rad France, Bio-Rad France Holding, Bio-Rad Germany Holding GmbH, Bio-Rad Haifa Ltd., Bio-Rad Holdings LLC, Bio-Rad Hungary Trading LLC, Bio-Rad IHC Europe GmbH, Bio-Rad Innovations, Bio-Rad Korea Ltd., Bio-Rad Laboratories (Canada) Limited, Bio-Rad Laboratories (India) Private Limited, Bio-Rad Laboratories (Israel) Inc., Bio-Rad Laboratories (Pty) Ltd, Bio-Rad Laboratories (Shanghai) Co. Ltd., Bio-Rad Laboratories (Singapore) Pte Ltd, Bio-Rad Laboratories AB, Bio-Rad Laboratories AG, Bio-Rad Laboratories B.V., Bio-Rad Laboratories Ges.m.b.H., Bio-Rad Laboratories GmbH, Bio-Rad Laboratories K.K., Bio-Rad Laboratories Limited, Bio-Rad Laboratories Logistik GmbH, Bio-Rad Laboratories Ltd., Bio-Rad Laboratories M.EPE, Bio-Rad Laboratories NV, Bio-Rad Laboratories Pty Ltd, Bio-Rad Laboratories S.A., Bio-Rad Laboratories S.r.l., Bio-Rad Laboratories SAS, Bio-Rad Laboratories-Aparelhos e Reagentes para Laboratórios Lda, Bio-Rad Laboratorii OOO, Bio-Rad Laboratórios Brasil Ltda., Bio-Rad Luxembourg S.à r.l., Bio-Rad Medical Diagnostics GmbH, Bio-Rad Middle East FZ-LLC, Bio-Rad Norway AS, Bio-Rad Pacific Limited, Bio-Rad Polska Sp. z o.o., Bio-Rad QL Inc., Bio-Rad S.A., Bio-Rad Services France, Bio-Rad Services UK Limited, Blackhawk Biosystems, Bridger Technologies Inc., Celsee, DiaMed (G.B.) Ltd, DiaMed (Schweiz) GmbH, DiaMed Benelux NV, DiaMed Diagnostika Deutschland GmbH, DiaMed Fennica Oy, DiaMed France SA, DiaMed GmbH, DiaMed Holding AG, DiaMed Holding GmbH, DiaMed Latino-América S.A., DiaMed S.E.A. Limited, DiaMed Österreich GmbH, Distribudora de Analítica para la Medicina Ibérica S.A.U., GnuBIO Inc., IMV Medical Information Division Inc., International Marketing Ventures Ltd., MJ GeneWorks, QuantaLife, Raindance Technologies Limited, Raindance Techologies Inc., Research Specialties for Laboratories NV, Respiratory Diagnostics Inc., and Wuxi BioCanal Nano Technology Co. Ltd..

When was Bio-Rad Laboratories founded?

Bio-Rad Laboratories was founded in 1952.

What is Bio-Rad Laboratories' official website?

The official website for Bio-Rad Laboratories is www.bio-rad.com.

Where are Bio-Rad Laboratories' headquarters?

Bio-Rad Laboratories is headquartered at 1000 ALFRED NOBEL DR, HERCULES CA, .

How can I contact Bio-Rad Laboratories?

Bio-Rad Laboratories' mailing address is 1000 ALFRED NOBEL DR, HERCULES CA, . The company can be reached via phone at 510-724-7000 or via email at [email protected].


This page was last updated on 9/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.